CDC Seeks Public Comments Regarding Chronic Pain Management
NORML
APRIL 30, 2020
percent in 2016).” ” This finding is hardly a surprise, as cannabis is well-established to mitigate pain in clinical models, particularly in patients with neuropathy.
NORML Formally Responds to DEA’s Proposed Changes to Marijuana Cultivation Rules
NORML
APRIL 8, 2020
The National Organization for the Reform of Marijuana Laws (NORML) has formally submitted comments to the US Federal Register opposing the Drug Enforcement Administration’s proposed rule changes governing the federal production and distribution of cannabis for clinical research purposes.
Cultivation 
349
349 Join 14,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Trending Sources
Legislation To Produce And Research Cannabis Introduced
NORML
JANUARY 17, 2019
A bipartisan coalition of House lawmakers has introduced The Medical Cannabis Research Act of 2019 ( HR 601 ), to facilitate federally-approved clinical trials involving cannabis. Click here to send a message to your Representative and urge them to support the measure. . The agency ultimately rejected her decision.
Clinical Trials 228
228 
Study: Marijuana Provided For FDA-Approved Clinical Research Genetically Similar to Hemp
NORML
APRIL 15, 2019
Clinicians wishing to conduct FDA-approved clinical trials on cannabis have long complained that federally-provided samples are of inferior quality. According to the program’s current marijuana menu , no available samples contain more than seven percent THC and all samples contain less than one percent CBD.
Hemp 197
197 Justice Department Urged To Take “Immediate Action” On Marijuana Grow Applications
NORML
MARCH 1, 2019
Currently, the sole federally licensed producer of cannabis for clinical research is the University of Mississippi. ” He later acknowledged that these restrictions have led many “companies [to] go overseas to conduct research with foreign-grown product that is more easily sourced for the purposes of clinical trials.”
DEA 195
195 
Court Dismisses Case Demanding DEA to Move Expeditiously to License Cannabis Cultivators
NORML
OCTOBER 21, 2019
The agency in 2016 first announced its intent to license private entities to grow cannabis for FDA-approved clinical trials. Since 1968, the agency has only licensed the University of Mississippi to engage in the growing of cannabis for FDA-approved clinical research.
DEA 103
103 
NORML “Senate Unanimously Approves Legislation Providing US Attorney General with Greater Say in Cannabis Research Decisions”
Cannabis Law Report
MARCH 30, 2022
Senate Bill 253: The Cannabidiol and Marihuana Research Expansion Act provides the office of US Attorney General, rather than the US Drug Enforcement Administration, the discretion to license scientists to engage in clinical trials involving the use of cannabis by human subjects.
Legislation 95
95 
Cannabis laws in Japan: Is weed legal?
The Cannigma
MAY 19, 2021
Since 2016, the country has permitted the sale of CBD and some Japanese companies produce cannabidiol products as well. In 2019, Japan approved clinical trials for Epidiolox — a cannabis derived medicine used to treat severe forms of childhood epilepsy such as Dravet and Lennox-Gastaut syndromes.
Law 140
140 
1 in 5 Parkinson’s Patients Use Cannabis
CannaMD
JUNE 2, 2021
” They cited the need for more and better patient education on the potential use of marijuana for the treatment of Parkinson’s disease, as well as the need for treating physicians to become better informed on the subject, and the need for more clinical trials.
Patients 105
105 
Real Money Publish A List Of Psychedelic Capitalist Roaders
Cannabis Law Report
SEPTEMBER 1, 2021
The company recently became the industry’s first firm to list on the NYSE American exchange and their psilocybin clinical trial for depression is making excellent progress. His background is a mix of cognitive psychology, clinical psychology and computer science. Joseph del Moral is CEO and co-founder of Field Trip.
Cannabis laws in San Marino
The Cannigma
OCTOBER 14, 2022
A limited form of medical marijuana has been legal in San Marino since 2016. Established in 2016 by a citizen’s initiative, patients can purchase cannabis-based medicines like Sativex to treat a number of approved conditions including multiple sclerosis, spine injuries, and neuropathic pain. Is weed legal in San Marino?
Law 56
56 
Ohio Gives Another Shot at Expanding Qualifying Conditions
Veriheal
NOVEMBER 17, 2020
Ohio became the 25th state to legalize medical cannabis back on June 8 of 2016. He ran clinical trials for big pharma’s GW Pharmaceuticals research division on Epidiolex. The 34 th largest state by area and the seventh most populated state in our country is Ohio, aka the Buckeye state.
Conditions 98
98 New Frontiers in the Law of Psychedelics
Cannabis Law Report
JULY 9, 2021
Then, in November 2019, the FDA granted the designation to the nonprofit Usona Institute to study psilocybin’s effect on major depressive order, for which clinical trials are currently under way. See Usona Institute, A Study of Psilocybin for Major Depressive Disorder (MDD) , Clinical Trial ID NCT03866174, available at [link].
Law 81
81 
More than half of prescriptions for medicinal cannabis in Australia given in Queensland, study says
Cannabis Law Report
MAY 10, 2022
Medicinal cannabis products such as capsules, creams, oils, lozenges, sprays and granulated flowers were approved for prescription 159,665 times between the start of Australia’s medicinal cannabis program in February 2016 and September 2021, research led by the University of Sydney’s Lambert Initiative for Cannabinoid Therapeutics shows.
Medicine 52
52 
Medical Marijuana for Severe Migraines
LifeCannMD
AUGUST 2, 2024
More clinical trials are needed to establish definitive efficacy and safety profiles. – Details: The research emphasized the need for controlled clinical trials to better understand the optimal dosages and strains. The study also noted that patients using medical cannabis had improved quality of life.
Vice Article: Australians Can Get a Medicinal Cannabis Prescription for Pretty Much Anything
Cannabis Law Report
MAY 10, 2022
Of the 248,000 scripts approved for Australians since inception of national medicinal cannabis scheme in 2016, many related to conditions for which the drug has limited evidence of efficacy, a new University of Sydney study shows. The findings were published today in Frontiers in Pharmacology.
Medicine 52
52 
NIDA Monopoly is Over: New DEA-Registered Cannabis Growers Can Supply Researchers with Product
Cannabis Law Report
NOVEMBER 4, 2021
In 2016, Dr. Sue Sisley first applied to grow cannabis for research purposes when the Obama administration announced a plan to allow other growers to provide cannabis to researchers. Use the plants for their own studies and/or FDA clinical trials. Drug Enforcement Agency (DEA) to cultivate marijuana for research purposes.
DEA 52
52 
8 famous people you didn’t know were cannabis patients
The Cannigma
SEPTEMBER 21, 2021
“I’ve actually tried (marijuana) twice during the last year and a half when I’ve been going through this pain, this chronic pain that I’ve been dealing with,” Kerr said in a 2016 interview. He added that “I tried it, and it didn’t help at all. But it was worth it, because I’m searching for answers on pain. 7) Morgan Freeman.
Patients 96
96 
Apparently Aussie Cannabis Stock Is “Smoke Without Fire.” All Australians Know At The Moment Smoke & Fire Come Together
Cannabis Law Report
DECEMBER 14, 2019
Medical cannabis was legalized in Australia in 2016 when the Narcotic Drugs Act was amended, allowing cannabis to be grown for medical and scientific purposes. Investing in cannabis stocks on the ASX: Risks and benefits for ASX pot stocks. Writes Investing News.com.
Global Legal Cannabis Markets Analysis 2021-2028 by Sources (Marijuana, Hemp), End-use (Recreational, Medical), Derivatives (CBD, THC) – ResearchAndMarkets.com
Cannabis Law Report
SEPTEMBER 9, 2021
Global Legal Cannabis Industry: Number of Clinical Trials, By Region. Estimated Number of Cannabis Users from 2016 to 2026, By Country. Estimated Number of Medical Marijuana Users from 2016 to 2026, By Country. Estimated Number of Cannabis Users from 2016 to 2026, By Country. Market Segmentation. Market Dynamics.
Recreational 73
73 
Marijuana and HIV: Much More Than Palliative Aid
Greencamp
FEBRUARY 2, 2019
2016 ( 3 ). But I haven’t seen any clinical trials looking at the direct effects of THC on the virus. Burggren, Ahoo Karimian, Taylor Kuhn; Combined Effects of HIV and Marijuana Use on Neurocognitive Functioning and Immune Status; 2016; 328-332. That’s a good thing if there is a lower amount of the virus. Shade, Steven G.
Marijuana 110
110 
South Australia: Is Adelaide About To See A Medical Cannabis Boom?
Cannabis Law Report
SEPTEMBER 1, 2019
By early 2016, Australia’s federal parliament passed a bill that laid the groundwork for cannabis to be legally cultivated and manufactured for medicinal and scientific purposes here. In late 2016, Faenza was working with a team to identify potential Australian sites and scan the international market for the best production methods.
MAPS Is 36 Years Old – Doblin Provides Precis Timeline of the Organization
Cannabis Law Report
APRIL 8, 2022
This year, we are completing the second Phase 3 clinical trial of MDMA-assisted therapy for PTSD , the final stage prior to requesting FDA approval for a new prescription treatment to help heal trauma. For over three decades, we’ve been working to achieve mass mental health throughout the United States, Canada, and Europe.
Australia TGA Stats Say More Patients Are Getting Access To Medical Cannabis
Cannabis Law Report
JANUARY 21, 2020
The figures do not include patients accessing medicinal cannabis outside the SAS via the Authorised Prescriber scheme or a clinical trial. However, the TGA notes a majority of the approvals have occurred since 2016, the year Australia’s Narcotics Act was amended. Source: [link].
Access 45
45 
Debunked: Study Linking Cannabis Use and Metabolic Syndrome
Freedom Leaf
JULY 20, 2017
Specifically, a 2016 study involving a significantly larger cohort of NHANES participants reported that “current marijuana use is associated with lower odds of metabolic syndrome.” “Longitudinal research is required to define the true relationship between marijuana use and metabolic syndrome.”
Article: Cannabis & CBD Pharma NewsNews Does medicinal cannabis actually help Australian patients?
Cannabis Law Report
AUGUST 19, 2019
There have been more than 7,500 approvals for medicinal cannabis in Australia since legalisation in 2016 – so why don’t we know if it is helping patients? Access to medicinal cannabis for patients was legalised in Australia in 2016, allowing doctors to request permission to prescribe from the Australian government.
Medicine 45
45 
Anebulo Pharmaceuticals Names Biotechnology Industry Executive Simon Allen as CEO and Director
Cannabis Law Report
JANUARY 4, 2022
“I am so very proud of all Anebulo has achieved over the past 18 months, including building out a highly effective team, securing new intellectual property protection, preparing and starting a proof-of-concept clinical trial, advancing regulatory discussions with the U.S.
Outline – Hopgood & Ganim Lawyers: Medicinal Cannabis in Australia: issues and regulations
Cannabis Law Report
APRIL 8, 2019
Through the Narcotic Drugs Amendment Act 2016 (Cth) and its amendments to the Narcotic Drugs Act 1967 (Cth) ( NDA ), the Australian Government commenced the legalisation of medicinal cannabis products in Australia under federal law in 2016. Josh Hunt – Partner. Callum Twigger – Lawyer. Chapter 2 of the NDA.
Medicine 71
71 
Creso Pharma Trading Halt Due To Police Raid On Sydney Stockbroker EverBlu Capital. Both Companies Helmed By Same Man
Cannabis Law Report
NOVEMBER 17, 2021
Creso Pharma was set up to develop, register and commercialise pharmaceutical-grade cannabis and hemp-based nutraceutical products and treatments in 2015, and listed on the ASX in 2016. It is the sort of stock that bounces around at the smaller end of the market, at the whim of day-traders and at times online investing forums.
Study: CBD “Promising” Therapy for Cocaine Addiction
CannaMD
AUGUST 26, 2020
Note: No human studies were found (with the exception of one clinical trial that was ongoing and therefore not selected); all studies focused on animals (i.e., After the full-text analyses, 14 were selected for the present review. Most studies were published in the last five years, while the rest were published between 1994 and 2008.
Therapy 98
98 
Meredith Fisher-Corn, MD…….”Are You Able to Answer Your Patients’ Medical Marijuana Questions”
TheAnswerPage
JANUARY 11, 2022
Some patients put faith in anecdotal reports or the encouraging results of observational studies, but anecdotal reports and observational studies are not double blind randomized controlled clinical trials and do not prove that a treatment is or is not effective. Meredith Fisher-Corn, MD, along with Stephen B.
Patients 98
98 North America Legal Cannabis Market Size, Share & Trends Analysis Report 2022 – ResearchAndMarkets.com
Cannabis Law Report
JANUARY 24, 2022
North America Legal Cannabis Number of clinical trials. Hemp Market Estimates and Forecasts, 2016-2028 (USD Million). Marijuana Market Estimates and Forecasts, 2016-2028 (USD Million). Medical Use Market Estimates and Forecasts, 2016-2028 (USD Million). Market Segmentation. Market Dynamics. Market Driver Analysis.
Legalization 40
40 
Australia – Baker & McKenzie Article: Reforms underway for Medicinal Cannabis in Australia
Cannabis Law Report
OCTOBER 3, 2019
Professor John McMillan AO’s review was conducted on the extensive amendments made to the ND Act in 2016, which established a regime for the cultivation, production and manufacture of medicinal cannabis in Australia. The number of applications received was three times higher than that which was forecasted in 2016.
Medicine 40
40 
Is cannabis legal in Australia?
The Cannigma
AUGUST 26, 2021
The country legalized medical cannabis in 2016, but patients in the country have long criticized the program as too restrictive, and access to cannabis-based medicines remains behind that of many other legal cannabis jurisdictions. percent) remains far higher than the world average (3.9 Costs of medical marijuana.
Legalization 52
52 
Pioneering Medical Cannabis Down Under
SpeedWeed
AUGUST 4, 2021
I attended my first medical cannabis symposium in Sydney in 2016. This event saw doctors and researchers from all over the world presenting the scientific and clinical studies surrounding the medical benefits of cannabis. . They presented case studies about patients who have had incredible success from their cannabis treatments.
Chronic Pain 52
52 
Guest Post: Is CBD Legal? Federal & State Laws [2019]
Cannabis Law Report
MARCH 21, 2019
In order to legally posses CBD in Alabama , you must be in accordance to Leni’s Law which states you must be diagnosed with a debilitating medical condition and be undergoing treatment or you are part of a state-sponsored clinical trial. In 2016, Tennessee legalized the use of CBD containing no more than 0.9%
State Laws 55
55 US Hemp Roundtable: Statement On The Status of Hemp Derived CBD Under Federal Law
Cannabis Law Report
JANUARY 11, 2019
However, we firmly disagree that the referenced clinical trials are in fact “substantial,” as the trials were extremely limited in scope, and funding and the publication of these trials were limited.
Hemp 49
49 
Beauty’s New High: CBD Oil
Weedistry
MARCH 11, 2019
Founded in 2016 by Robert Rosenheck, who has a branding background, and his wife, Cindy Capobianco, who has led public relations for Banana Republic and marketing for Gap, it is a leader in a movement to make marijuana more attractive to a mainstream audience. “It It really does work for pain management.”.
Oil 40
40 MediPharm Labs Enters into Agreements with Australian Licensed Producer & Forms Multiple Cannabis Supply Partnerships to Advance Australian Market Leadership
Cannabis Law Report
SEPTEMBER 3, 2019
Federal legislation to enable the production and sale of cannabis for medical use and related research purposes was passed by Australia’s parliament in 2016. “Our licences are fundamental assets and we welcome the scrutiny of regulators as we establish our place in the market.”. Australian Leadership Appointments.
Paper: The transition of cannabis into the mainstream of Australian healthcare: framings in professional medical publications
Cannabis Law Report
NOVEMBER 24, 2021
Medicinal cannabis has been legalised for use for a range of specified medical conditions in Australia since 2016. Legalisation occurred in Australia in 2016. 2016 ; Sznitman et al. Before 2016, Australian law considered cannabis an illegal drug. This was followed by a TGA report in 2019 reviewing the 2016 amendments.
Article: Canada: Future Care Costs For Cannabis In Personal Injury Claims
Cannabis Law Report
JUNE 11, 2019
While there is anecdotal evidence that CBD does have beneficial properties, I heard no evidence that that claim has been established through recognized clinical trials. White , 2016 BCSC 569. Kaur , 2016 BCSC 692. Ahn , 2016 BCSC 795, reversed on other grounds 2017 BCCA 221. Gaston , 2016 BCSC 1401.
Chronic Pain 45
45 
Dentons’ Cannabis Group Latest Weekly Update – June 2019 #4
Cannabis Law Report
JUNE 30, 2019
Lou Correa (D-CA) that would require the VA to conduct clinical trials on the therapeutic potential of cannabis in the treatment of such service-related conditions as post-traumatic stress disorder and chronic pain. The panel also took up a bill sponsored by Rep.
Chronic Pain 40
40 
New Study: Demographic and policy-based differences in behaviors and attitudes towards driving after marijuana use: an analysis of the 2013–2017 Traffic Safety Culture Index
Cannabis Law Report
JUNE 10, 2021
Washington, DC: AAA Foundation for Traffic Safety; 2016. GfK KnowledgePanel 2016. 9-tetrahydrocannabinol on driving performance: a randomized clinical trial. Arnold LS, Tefft BC. Driving under the influence of alcohol and marijuana: beliefs and behaviors, United States, 2013–2015. Google Scholar. Article Google Scholar.
Policy 45
45 
First ethics at MAPS in question and now Australia’s Mind Medicine look to have some serious integrity issues too
Cannabis Law Report
JULY 25, 2022
Reporter Elise Worthington also investigates the dark side of this form of therapy where disturbing cases of abuse and malpractice are emerging in both clinical trials and the underground. Here’s the precis to the show. ” Underground researcher.
Medicine 52
52 
Let's personalize your content